1 Abela IA, Pasin C, Schwarzmüller M, Epp S, Sickmann ME, Schanz MM, et al. Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity [Internet]. medRxiv [Preprint]. 2021;
doi:10.1101/2021.04.21.21255410 [cited 2021 June 22]. Available from:
https://doi.org/10.1101/2021.04.21.21255410
2 Health Information and Quality Authority. Evidence summary for the duration of infectiousness in those that test positive for SARS-CoV-2 RNA [Internet]. Dublin: HIQA; 2020 [cited 2021 Feb 25]. Available from:
https://www.hiqa.ie/sites/default/files/2020-09/Evidence-summary-for-duration-of-infectiousness-of-SARS-CoV-2.pdf.
3 European Centre for Disease Prevention and Control. Guidance for discharge and ending of isolation of people with COVID-19 [Internet]. Solna (Sweden): ECDC; 2020 [cited 2021 Feb 24]. Available from:
https://www.ecdc.europa.eu/en/publications-data/covid-19-guidance-discharge-and-ending-isolation
4 Swissnoso. Interims Vorsorgemassnahmen in Spitälern für einen hospitalisierten Patienten mit begründetem Verdacht oder mit einer bestätigten COVID-19 Infektion (Version 8.6) [Internet]. Bern: Swissnoso; 2020 [cited 2021 Feb 24]. Available from:
https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Erreignisse/201211_Vorsorgemassnahmen_COVID-19_Spital_V8.6_DE.pdf
6 van Kampen JJA, van de Vijver DAMC, Fraaij PLA, Haagmans BL, Lamers MM, Okba N, et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun. 2021;12(1):267.